Skip to main content
Published locations for Resectable HCC: Neoadjuvant cemiplimab appears effective and safe in phase 2
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Resectable HCC: Neoadjuvant cemiplimab appears effective and safe in phase 2
User login
Username
Password
Reset your password
/content/resectable-hcc-neoadjuvant-cemiplimab-appears-effective-and-safe-phase-2-0
/gihepnews/article/252045/hepatocellular-carcinoma/resectable-hcc-neoadjuvant-cemiplimab-appears